108 related articles for article (PubMed ID: 31502798)
1. [Pathway times in the mammography programme before and after introduction of the breast cancer care pathway].
Tsuruda KM; Bhargava S; Akslen LA; Bjørndal H; Hofvind S
Tidsskr Nor Laegeforen; 2019 Sep; 139(12):. PubMed ID: 31502798
[TBL] [Abstract][Full Text] [Related]
2. Waiting time for breast cancer surgery in Quebec.
Mayo NE; Scott SC; Shen N; Hanley J; Goldberg MS; MacDonald N
CMAJ; 2001 Apr; 164(8):1133-8. PubMed ID: 11338798
[TBL] [Abstract][Full Text] [Related]
3. Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program.
Chiarelli AM; Mai V; Halapy EE; Shumak RS; O'Malley FP; Klar NS
Can J Public Health; 2005; 96(4):259-63. PubMed ID: 16625791
[TBL] [Abstract][Full Text] [Related]
4. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.
Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA
Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926
[TBL] [Abstract][Full Text] [Related]
6. [Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012].
Pourcel G; Ledesert B; Bousquet PJ; Ferrari C; Viguier J; Buzyn A
Bull Cancer; 2013 Dec; 100(12):1237-50. PubMed ID: 24158562
[TBL] [Abstract][Full Text] [Related]
7. Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Guren MG; Haug ES; Naume B; Schlichting E; Møller B
BMC Cancer; 2022 Feb; 22(1):220. PubMed ID: 35227226
[TBL] [Abstract][Full Text] [Related]
8. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
Lehman CD; Arao RF; Sprague BL; Lee JM; Buist DS; Kerlikowske K; Henderson LM; Onega T; Tosteson AN; Rauscher GH; Miglioretti DL
Radiology; 2017 Apr; 283(1):49-58. PubMed ID: 27918707
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer mortality in Norway after the introduction of mammography screening.
Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
[TBL] [Abstract][Full Text] [Related]
10. Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway.
Nilssen Y; Brustugun OT; Tandberg Eriksen M; Gulbrandsen J; Skaaheim Haug E; Naume B; Møller B
Cancer Epidemiol; 2019 Aug; 61():59-69. PubMed ID: 31153048
[TBL] [Abstract][Full Text] [Related]
11. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
[TBL] [Abstract][Full Text] [Related]
12. [Extension of the target age range of mammography screening programme and governance of mammography practice in the Emilia-Romagna Region (Northern Italy)].
Sassoli de Bianchi P; Ravaioli A; Ferretti S; Finarelli AC; Giannini A; Naldoni C; Sanna P; Bucchi L
Epidemiol Prev; 2017; 41(1):38-45. PubMed ID: 28322527
[TBL] [Abstract][Full Text] [Related]
13. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
14. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
15. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
Roder D; Webster F; Zorbas H; Sinclair S
Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of breast cancer in Norway 2003-2018.
Skjerven HK; Danielsen AS; Schlichting E; Sahlberg KK; Hofvind S
Tidsskr Nor Laegeforen; 2020 Oct; 140(15):. PubMed ID: 33118768
[TBL] [Abstract][Full Text] [Related]
17. Waiting time disparities in breast cancer diagnosis and treatment: a population-based study in France.
Molinié F; Leux C; Delafosse P; Ayrault-Piault S; Arveux P; Woronoff AS; Guizard AV; Velten M; Ganry O; Bara S; Daubisse-Marliac L; Tretarre B
Breast; 2013 Oct; 22(5):810-6. PubMed ID: 23473773
[TBL] [Abstract][Full Text] [Related]
18. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
19. Breast compression across consecutive examinations among females participating in BreastScreen Norway.
Waade GG; Sebuødegård S; Hogg P; Hofvind S
Br J Radiol; 2018 Oct; 91(1090):20180209. PubMed ID: 29927636
[TBL] [Abstract][Full Text] [Related]
20. Patient experiences of waiting times in standardised cancer patient pathways in Norway - a qualitative interview study.
Solbjør M; Sand K; Ervik B; Melby L
BMC Health Serv Res; 2021 Jul; 21(1):651. PubMed ID: 34225705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
